You are here

Article info

Article menu

Download PDFPDF

XML
Immune cell therapies and immune cell engineering
CARs and beyond: tailoring macrophage-based cell therapeutics to combat solid malignancies

Authors

  • Shifaa M. Abdin Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, GermanyREBIRTH Research Center for Translational and Regenerative Medicine, Hannover Medical School, Hannover, Germany PubMed articlesGoogle scholar articles
  • Daniela Paasch REBIRTH Research Center for Translational and Regenerative Medicine, Hannover Medical School, Hannover, GermanyInstitute of Experimental Hematology, Hannover Medical School, Hannover, Germany PubMed articlesGoogle scholar articles
  • Michael Morgan REBIRTH Research Center for Translational and Regenerative Medicine, Hannover Medical School, Hannover, GermanyInstitute of Experimental Hematology, Hannover Medical School, Hannover, Germany PubMed articlesGoogle scholar articles
  • Nico Lachmann Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, GermanyREBIRTH Research Center for Translational and Regenerative Medicine, Hannover Medical School, Hannover, GermanyRESIST, Cluster of Excellence, Hannover Medical School, Hannover, GermanyBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Nico Lachmann; lachmann.nico{at}mh-hannover.de
View Full Text

Citation

Abdin SM, Paasch D, Morgan M, et al
CARs and beyond: tailoring macrophage-based cell therapeutics to combat solid malignancies
Journal for ImmunoTherapy of Cancer 2021;9:e002741. doi: 10.1136/jitc-2021-002741

Publication history

  • Accepted July 25, 2021
  • First published August 30, 2021.
Online issue publication 
November 02, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.